News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,661 Results
Type
Article (86491)
Company Profile (702)
Press Release (759468)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232682)
Career Advice (4127)
Deals (39721)
Drug Delivery (129)
Drug Development (90984)
Employer Resources (198)
FDA (18107)
Job Trends (17334)
News (396460)
Policy (39748)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56834)
ALS (101)
Alzheimer's disease (1504)
Antibody-drug conjugate (ADC) (161)
Approvals (18068)
Artificial intelligence (329)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (306)
Cancer (2461)
Cardiovascular disease (207)
Career advice (3534)
Career pathing (34)
CAR-T (175)
Cell therapy (496)
Cervical cancer (22)
Clinical research (73430)
Collaboration (921)
Company closure (1)
Compensation (572)
Complete response letters (30)
COVID-19 (2868)
CRISPR (49)
C-suite (271)
Cystic fibrosis (108)
Data (2304)
Decentralized trials (2)
Denatured (45)
Depression (56)
Diabetes (301)
Diagnostics (6924)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (129)
Drug shortages (33)
Duchenne muscular dystrophy (103)
Earnings (96772)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130094)
Executive appointments (783)
FDA (19477)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (826)
Gene editing (123)
Generative AI (35)
Gene therapy (362)
GLP-1 (856)
Government (5163)
Grass and pollen (6)
Guidances (92)
Healthcare (20888)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (149)
Indications (30)
Infectious disease (3030)
Inflammatory bowel disease (157)
Inflation Reduction Act (11)
Influenza (58)
Intellectual property (102)
Interviews (812)
IPO (17820)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (559)
Leadership (24)
Legal (10114)
Liver cancer (82)
Lung cancer (347)
Lymphoma (160)
Machine learning (7)
Management (65)
Manufacturing (360)
MASH (76)
Medical device (14640)
Medtech (14645)
Mergers & acquisitions (22451)
Metabolic disorders (797)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (34)
Neuroscience (2114)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (40)
Obesity (428)
Opinion (275)
Ovarian cancer (79)
Pain (103)
Pancreatic cancer (89)
Parkinson's disease (161)
Partnered (24)
Patents (255)
Patient recruitment (117)
Peanut (51)
People (65321)
Pharmaceutical (143)
Pharmacy benefit managers (22)
Phase I (22662)
Phase II (31880)
Phase III (24022)
Pipeline (1306)
Policy (174)
Postmarket research (3552)
Preclinical (10227)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (431)
Real estate (7392)
Recruiting (75)
Regulatory (26813)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (93)
Service/supplier (30)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4292)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (49)
The Weekly (82)
Vaccines (816)
Venture capitalists (44)
Weight loss (305)
Women's health (40)
Worklife (20)
Date
Today (143)
Last 7 days (792)
Last 30 days (2978)
Last 365 days (35784)
2025 (12200)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (50147)
Australia (8831)
California (6540)
Canada (2079)
China (570)
Colorado (285)
Connecticut (304)
Delaware (164)
Europe (115036)
Florida (948)
Georgia (221)
Hawaii (1)
Idaho (64)
Illinois (637)
India (31)
Indiana (337)
Iowa (12)
Japan (173)
Kansas (111)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (975)
Massachusetts (5002)
Michigan (250)
Minnesota (425)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (66)
New Hampshire (70)
New Jersey (1838)
New Mexico (31)
New York (1846)
North Carolina (1139)
North Dakota (9)
Northern California (2804)
Ohio (222)
Oklahoma (15)
Oregon (48)
Pennsylvania (1438)
Puerto Rico (13)
Rhode Island (36)
South America (1653)
South Carolina (25)
South Dakota (1)
Southern California (2424)
Tennessee (105)
Texas (983)
United States (25059)
Utah (195)
Virginia (173)
Washington D.C. (71)
Washington State (609)
West Virginia (3)
Wisconsin (72)
There are 846,661 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)
May 7, 2025
·
5 min read
Press Releases
Caresyntax and The Jacobs Institute Announce Strategic Collaboration to Advance Surgical Insights and Real-World Evidence Generation
May 7, 2025
·
3 min read
Press Releases
ECM Therapeutics Receives FDA IDE Approval for U.S. Feasibility Study of ECMT-100 in Treatment of Anorectal Fistulas
May 7, 2025
·
1 min read
Press Releases
eGenesis Appoints Dr. Jay Barth as Chief Medical Officer
May 7, 2025
·
3 min read
Press Releases
Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13
May 7, 2025
·
1 min read
Press Releases
Forge Biologics Announces Eight Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
May 7, 2025
·
3 min read
Press Releases
Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists
May 7, 2025
·
5 min read
Press Releases
iECURE to Present Initial OTC-HOPE Clinical Data of ECUR-506 in Ornithine Transcarbamylase Deficiency at Upcoming Medical Meetings
May 7, 2025
·
4 min read
Press Releases
CorFlow Therapeutics Appoints Chris O’Connell as Chairman of the Board of Directors
May 7, 2025
·
3 min read
Press Releases
Phillips Medisize Announces Scientific Presentations and Engagements at Respiratory Drug Delivery Conference, Highlighting Its Expanded Inhalation Drug Delivery Capabilities
May 7, 2025
·
3 min read
1 of 84,667
Next
